The calibration, inspection, and/or qualification of the equipment, including computerized systems, was inadequate.
Inspection Record
Shiseido Canada Inc. — Health Canada Inspection Findings
View the regulator's official source The source document is always the basis for judgement.
Findings
The assessment, documentation, and/or procedures for considering the resale of returned drugs were inadequate.
The training of personnel in good manufacturing practices and/or the maintenance of records was inadequate.
The change control system was inadequate for ensuring changes are properly documented, evaluated, and/or approved.
Investigations into deviations, reports, and/or follow-up actions were inadequate.
The master formula for packaged products did not include the required information.
About this record
Extracted automatically from the document of the Health Canada inspection on 2023-08-02. The source is available at the link above.
This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.
Translation and classification are automated and may differ in nuance from the source.
